Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Samalizumab Biosimilar - Anti-CD200 mAb - Research Grade |
---|---|
Source | CAS 1073059-33-2 |
Species | Humanized |
Expression system | Mammalian cells |
Purity | >85% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Applications | ELISA,WB |
Aliases /Synonyms | Samalizumab,ALXN6000,Anti-CD200,hB7V3V2 G2G4,CD200,anti-CD200 |
Reference | PX-TA1250 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG2-G4-kappa |
Clonality | Monoclonal Antibody |
Samalizumab has beeninvestigated for the treatment of Multiple Myeloma and B-cell Chronic Lymphocytic Leukemia.
Samalizumab Biosimilar - Anti-CD200 mAb, on SDS-PAGE under non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Reviews
Il n’y a pas encore d’avis.